-
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Membrane proteins are critical for cellular signaling and transport, making them prime targets for drug development in cardiovascular and inflammatory diseases. The P2X4 receptor is central to these pathways. However,…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Antibody production
Mastering Cell Line Development: From Basics to Innovations
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Custom Antibody
The Essentials of Antibody Engineering
Read more -
Antibody production
Phage Display vs. Hybridoma: Choosing the Right Method for Monoclonal Antibody Production
Read more
-
Antibody production
The Ultimate Guide to Phage Display Technology: Unlocking the Future of Monoclonal Antibody Development
Read more -
Antibody production
Everything you need to know about the structure and types of antibodies in the forefront of the immune response
Read more -
Antibody-drug conjugates
ADC linkers: Definition and examples
Read more -
Antibody production
Mastering Cell Line Development: From Basics to Innovations
Read more -
Peptide synthesis
What are the challenges in chemical and recombinant peptide production processes and how to overcome them?
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more